Motion Sickness Medication for Children: Safety, FDA Status & Alternatives

Most OTC motion sickness drugs (dimenhydrinate/Dramamine®, meclizine/Bonine®, diphenhydramine/Benadryl®) are not FDA-approved for children <12 years. Safety/efficacy data lacking.

Concerns

  • Sedation, dizziness → fall risk, impaired cognition.
  • Paradoxical excitation (agitation, hallucinations) in young children.
  • Anticholinergic effects: dry mouth, constipation, urinary retention.
  • Dosing not established for <12.

Prescription Options (Pediatric)

  • Ondansetron (Zofran®) – off-label for nausea; minimal sedation.
  • Scopolamine patch (Transderm Scop®) – approved ≥12 years; caution <12.
  • Promethazine – black box warning for respiratory depression in <2 years; avoid <6 years.

Non-Drug Strategies (First-Line for Kids)

  • Visual-Vestibular Alignment: Look at horizon, not screens/books. Front seat (if >13, airbag-safe).
  • Fresh Air: Open window, avoid strong odors.
  • Pre-Trip Meal: Light, bland (crackers, banana); avoid greasy/spicy.
  • Hydration: Small sips water/electrolyte solution.
  • Acupressure: P6 (Nei-Kuan) wristbands – mixed evidence, low risk.
  • Ginger: Chews, tea, capsules – some evidence for nausea.
  • Behavioral: Distraction (music, games), scheduled stops.

When to Consult a Pediatrician

  • Child <2 years.
  • Severe/prolonged symptoms.
  • Underlying conditions (migraine, vestibular disorder).
  • Need for prescription medication.

Prioritize non-pharmacologic approaches. If medication needed, use only under medical guidance with age-appropriate product.

Children's Health - Related Articles